TADIOS

· Helixmith Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TADIOS, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19 [Phase 2, Phase 3]

See pricing